IL1B and melanoma: In melanoma, macrophage-derived NLRP3/IL-1β pathway promotes migration and invasion of melanoma cells, which can be blocked through NLRP3 knockout, caspase-1 knockout, or NLRP3 inhibitor, celastrol [172].